These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37745365)

  • 1. A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinoma.
    Ho E; De Cecco L; Cavalieri S; Sedor G; Hoebers F; Brakenhoff RH; Scheckenbach K; Poli T; Yang K; Scarborough JA; Campbell S; Koyfman S; Eschrich SA; Caudell JJ; Kattan MW; Licitra L; Torres-Roca JF; Scott JG
    medRxiv; 2023 Sep; ():. PubMed ID: 37745365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
    Gabani P; Lin AJ; Barnes J; Oppelt P; Adkins DR; Rich JT; Zevallos JP; Daly MD; Gay HA; Thorstad WL
    Radiother Oncol; 2019 May; 134():81-88. PubMed ID: 31005228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of concomitant chemoradiotherapy in AJCC 7
    Lu DJ; Luu M; Nguyen AT; Shiao SL; Scher K; Mita A; Anderson E; Clair JM; Ho AS; Zumsteg ZS
    Oral Oncol; 2020 Nov; 110():104882. PubMed ID: 32650257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base.
    Amini A; Jasem J; Jones BL; Robin TP; McDermott JD; Bhatia S; Raben D; Jimeno A; Bowles DW; Karam SD
    Oral Oncol; 2016 May; 56():1-7. PubMed ID: 27086480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined chemoradiotherapy showed improved outcome with early-stage HPV-positive oropharyngeal cancers.
    Lu XJD; Jackson E; Chew J; Nguyen S; Wu J; Poh CF; Prisman E
    BMC Cancer; 2022 May; 22(1):513. PubMed ID: 35525912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
    Shiao JC; Holt D; Ladbury C; Gao D; Jones B; Karam SD; Amini A
    Oral Oncol; 2022 Jul; 130():105907. PubMed ID: 35605559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genomic characterization of chemoradiation-resistant HPV-positive oropharyngeal squamous cell carcinoma.
    Guo T; Zamuner F; Ting S; Chen L; Rooper L; Tamayo P; Fakhry C; Gaykalova D; Mehra R
    Front Oncol; 2024; 14():1336577. PubMed ID: 38505587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis.
    Scott JG; Sedor G; Ellsworth P; Scarborough JA; Ahmed KA; Oliver DE; Eschrich SA; Kattan MW; Torres-Roca JF
    Lancet Oncol; 2021 Sep; 22(9):1221-1229. PubMed ID: 34363761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas.
    Vijayvargiya P; Trivedi S; Rupji M; Song H; Liu Y; Jiang R; Kaka AS; Chen GZ; Stokes W; Steuer C; Shin DM; Beitler JJ; Patel MR; Aiken A; Saba NF
    Oncologist; 2022 Feb; 27(1):48-56. PubMed ID: 35305095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?
    Yoshida EJ; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Nguyen AT; Shiao SL; Ho AS; Zumsteg ZS
    Cancer; 2020 Jan; 126(1):58-66. PubMed ID: 31536144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
    Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice patterns and outcomes following radiation dose de-escalation for oropharyngeal cancer.
    White R; Abel S; Hasan S; Verma V; Greenberg L; Colonias A; Wegner RE
    Laryngoscope; 2020 Apr; 130(4):E171-E176. PubMed ID: 31120601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Impact of AJCC/UICC 8th Edition New Staging Rules in Oropharyngeal Squamous Cell Carcinoma.
    Würdemann N; Wagner S; Sharma SJ; Prigge ES; Reuschenbach M; Gattenlöhner S; Klussmann JP; Wittekindt C
    Front Oncol; 2017; 7():129. PubMed ID: 28713770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
    Elhalawani H; Mohamed ASR; Elgohari B; Lin TA; Sikora AG; Lai SY; Abusaif A; Phan J; Morrison WH; Gunn GB; Rosenthal DI; Garden AS; Fuller CD; Sandulache VC
    BMC Cancer; 2020 Sep; 20(1):912. PubMed ID: 32967643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.
    Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS
    J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Human Papilloma Virus and Lifestyle Factors in Overall Survival of Patients with Oropharyngeal Squamous Cell Carcinoma.
    Nishikawa D; Hanai N; Ozawa T; Kitahara T; Hasegawa Y
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification.
    Zeng PYF; Cecchini MJ; Barrett JW; Shammas-Toma M; De Cecco L; Serafini MS; Cavalieri S; Licitra L; Hoebers F; Brakenhoff RH; Leemans CR; Scheckenbach K; Poli T; Wang X; Liu X; Laxague F; Prisman E; Poh C; Bose P; Dort JC; Shaikh MH; Ryan SEB; Dawson A; Khan MI; Howlett CJ; Stecho W; Plantinga P; Daniela da Silva S; Hier M; Khan H; MacNeil D; Mendez A; Yoo J; Fung K; Lang P; Winquist E; Palma DA; Ziai H; Amelio AL; Li SS; Boutros PC; Mymryk JS; Nichols AC
    EBioMedicine; 2022 Dec; 86():104373. PubMed ID: 36442320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of TORS as De-Escalation Strategy in HPV-Related Oropharyngeal Cancer, What We Need to Know.
    Molteni G; Bassani S; Arsie AE; Zampieri E; Mannelli G; Orlandi E; Bossi P; De Virgilio A
    Healthcare (Basel); 2024 May; 12(10):. PubMed ID: 38786424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.